O Brien Greene & Co. Inc cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 7.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,400 shares of the company’s stock after selling 1,000 shares during the quarter. O Brien Greene & Co. Inc’s holdings in HealthEquity were worth $843,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in HealthEquity by 40.2% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 2,676 shares of the company’s stock worth $187,000 after acquiring an additional 767 shares in the last quarter. Cigna Investments Inc. New bought a new stake in shares of HealthEquity during the first quarter valued at approximately $201,000. Concorde Asset Management LLC purchased a new position in HealthEquity in the 1st quarter worth approximately $223,000. Campbell & CO Investment Adviser LLC bought a new position in HealthEquity in the 4th quarter valued at approximately $231,000. Finally, Creative Planning bought a new position in shares of HealthEquity during the fourth quarter valued at $246,000. 98.08% of the stock is currently owned by institutional investors and hedge funds.
NASDAQ:HQY traded up $0.21 on Friday, reaching $78.19. 4,621 shares of the company’s stock traded hands, compared to its average volume of 749,098. The stock’s 50-day moving average is $75.12. HealthEquity, Inc. has a 12 month low of $45.82 and a 12 month high of $93.32. The stock has a market capitalization of $6.52 billion, a price-to-earnings ratio of 649.83, a PEG ratio of 7.49 and a beta of 1.36. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.25 and a current ratio of 2.25.
In related news, insider Darcy G. Mott sold 6,000 shares of the stock in a transaction on Thursday, May 20th. The stock was sold at an average price of $77.25, for a total transaction of $463,500.00. Following the sale, the insider now owns 81,052 shares in the company, valued at approximately $6,261,267. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In the last quarter, insiders sold 18,000 shares of company stock valued at $1,315,080. 2.80% of the stock is currently owned by company insiders.
A number of equities analysts have weighed in on the company. Cantor Fitzgerald boosted their target price on HealthEquity from $82.00 to $85.00 and gave the stock an “overweight” rating in a research report on Tuesday. JPMorgan Chase & Co. assumed coverage on HealthEquity in a report on Thursday, April 29th. They set an “overweight” rating on the stock. Raymond James raised their price target on HealthEquity from $85.00 to $90.00 and gave the stock a “strong-buy” rating in a research note on Thursday. SVB Leerink increased their target price on HealthEquity from $77.00 to $80.00 and gave the company a “market perform” rating in a report on Tuesday, March 16th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $88.00 to $92.00 and gave the stock a “buy” rating in a research report on Wednesday, March 17th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $82.55.
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Story: Why are trading ranges significant?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.